Skip to main content
. 2020 Aug 16;12(8):2467. doi: 10.3390/nu12082467

Table 7.

Percentages of children meeting and not meeting European Food Safe Authority (EFSA) recommendations for main fatty acids by cohort and age group Figure 1448 ¥.

Spanish Reference Cohort (SRS)
Total 1 to <3 Years 3 to <6 Years 6 to <10 Years
n % BR % MR % AR£ n % BR % MR % AR£ n % BR % MR % AR£ n % BR % MR % AR£ p
Total Fat 707 13.7 41.7 44.6 162 42.0 35.8 a 22.2 244 11.9 50.8 b 37.3 301 0.0 37.5 a 62.5 <0.001
Linoleic acid 707 57.4 26.4 16.1 162 66.7 25.3 8.0 244 56.6 27.5 16.0 301 53.2 26.2 20.6 NS
α-Linolenic acid 707 99.0 1.0 0.0 162 98.8 1.2 0.0 244 99.6 0.4 0.0 301 98.7 1.3 0.0 NS
EPA+DHA 707 73.4 2.4 24.2 162 73.5 1.9 24.7 244 75.0 2.0 23.0 301 72.1 3.0 24.9 NS
Adapted Milk Consumers Cohort (AMS)
Total 1 to <3 Years 3 to <6 Years 6 to <10 Years
n % BR % MR % AR£ n % BR % MR % AR£ n % BR % MR % AR£ n % BR % MR % AR£ p
Total Fat 741 27.9 * 37.1 * 35.0 * 294 56.5 * 35.0 a 8.5 * 262 15.6 45.0 b 39.3 185 0.0 29.2 a 70.8 <0.001
Linoleic acid 741 64.6 * 24.4 * 10.9 * 294 77.9 * 13.9 a,* 8.2 262 53.8 32.4 b 13.7 185 58.9 29.7 b 11.4 * <0.001
α-Linolenic acid 741 96.6 * 2.4 * 0.9 * 294 93.2 * 4.8 a 2.0 262 99.2 0.4 b 0.4 185 98.4 1.6 a,b 0.0 <0.001
EPA+DHA 741 59.2 * 2.6 * 38.2 * 294 56.1 * 4.4 39.5 * 262 63.4 * 1.1 35.5 * 185 58.4 * 1.6 40.0 * NS

The percentage for inadequacy was calculated by comparing with EFSA recommendations. First column: percentage below recommendations (BR); second column: percentage meeting recommendations MR); third column: percentage above recommendations (AR). DHA, docosahexaenoic acid, 22:6 n-3; EPA, eicosapentaenoic acid, 20:5 n-3; NS, no significance. Results are expressed in percentage (%). ¥ Individual usual intake for two 24 h dietary recalls was used for total fats, linoleic acid, α-linolenic acid, SFAs, and PUFAs. Average gram intake values from two 24 h dietary recalls were used for EPA+DHA. Chi-square test was used to evaluate differences by total and age group between SRS and AMS (significant differences are marked with an asterisk * in the percentage values of the AMS cohort). Chi-square test analysis was used to calculate differences among age groups within cohorts (significant differences are marked with superscript letters in the value of each age group that is meeting the recommendations). £ The percentages of children above the recommendations do not exceed the tolerable upper intake limit. p-values for this test are included in the last column of the table. p-value <0.05 was considered statistically significant.